
LINK . SPRINGER . COM {
}
Title:
NSAIDs and breast cancer recurrence in a prospective cohort study | Cancer Causes & Control
Description:
Objective We examined the association between NSAID use and breast cancer recurrence in a prospective cohort of 2,292 early-stage breast cancer survivors diagnosed from 1997 to 2000 participating in the Life After Cancer Epidemiology (LACE) Study. Methods From 2000 to 2002, mailed questionnaires were used to obtain information on aspirin, ibuprofen, and other NSAID use and subsequent breast cancer events. A total of 270 recurrences (local, regional, and distant disease and new primary breast cancers) were reported and verified by medical record review. Cox proportional hazard models were used to estimate rate ratios (RR) and 95% confidence intervals (CI), adjusting for age at diagnosis, race, cancer stage, tamoxifen treatment, chemotherapy use, body mass index, and cyclooxygenase-2 (COX2) inhibitor use. Results Current, regular use (at least three days per week at time of questionnaire administration) of ibuprofen (RR, 0.56; 95% CI, 0.32β0.98), but not aspirin (RR, 1.09; 95% CI, 0.74β1.61), was associated with a statistically significant decreased risk of breast cancer recurrence. The combination of ibuprofen and other non-aspirin NSAIDs such as naproxen and sulindac reflected a similar reduction in risk (RR, 0.56; 95% CI, 0.33β0.95). No association was found for the non-NSAID analgesic acetaminophen. Conclusion Our findings provide support for an inverse association between current, regular ibuprofen use and breast cancer recurrence.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {π}
- Health & Fitness
- Education
- Science
Content Management System {π}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {π}
What is the average monthly size of link.springer.com audience?
π Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,734,772 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {πΈ}
We can't tell how the site generates income.
The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.
Keywords {π}
cancer, breast, article, google, scholar, pubmed, cas, study, nonsteroidal, antiinflammatory, risk, drugs, cyclooxygenase, aspirin, access, recurrence, cohort, association, privacy, cookies, content, control, prospective, ibuprofen, support, expression, data, information, publish, research, search, nsaids, kwan, slattery, nsaid, regular, open, res, log, journal, april, marilyn, habel, caan, lace, diagnosis, stage, results, women, discover,
Topics {βοΈ}
month download article/chapter steroidal anti-inflammatory drugs keywords anti-inflammatory agents nonsteroidal anti-inflammatory drugs nonsteroidal anti-inflammatory drug spanish multi-case-control breast cancer chemoprevention related subjects full article pdf privacy choices/manage cookies nonsteroidal antiinflammatory drugs breast cancer recurrence prospective cohort study invasive breast cancer breast cancer incidence human breast cancer primary breast cancers breast cancer risk national cancer institute european economic area medical record review estimate rate ratios body mass index hormone receptor status garcia rodriguez la randomized controlled trial rat mammary adenocarcinomas rat mammary carcinomas reis-filho js lymph node metastasis salt lake city breast cancer diagnosis findings provide support cyclo-oxygenase 2 expression conditions privacy policy bmc cancer 3 comparative chemopreventive activity cyclooxygenase-2 gene expression article cancer accepting optional cookies lace study staff utah cancer registry anticancer drug development elevated cyclooxygenase-2 expression author information authors check access instant access article log low-dose aspirin ibuprofen-induced inhibition
Schema {πΊοΈ}
WebPage:
mainEntity:
headline:NSAIDs and breast cancer recurrence in a prospective cohort study
description:We examined the association between NSAID use and breast cancer recurrence in a prospective cohort of 2,292 early-stage breast cancer survivors diagnosed from 1997 to 2000 participating in the Life After Cancer Epidemiology (LACE) Study. From 2000 to 2002, mailed questionnaires were used to obtain information on aspirin, ibuprofen, and other NSAID use and subsequent breast cancer events. A total of 270 recurrences (local, regional, and distant disease and new primary breast cancers) were reported and verified by medical record review. Cox proportional hazard models were used to estimate rate ratios (RR) and 95% confidence intervals (CI), adjusting for age at diagnosis, race, cancer stage, tamoxifen treatment, chemotherapy use, body mass index, and cyclooxygenase-2 (COX2) inhibitor use. Current, regular use (at least three days per week at time of questionnaire administration) of ibuprofen (RR, 0.56; 95% CI, 0.32β0.98), but not aspirin (RR, 1.09; 95% CI, 0.74β1.61), was associated with a statistically significant decreased risk of breast cancer recurrence. The combination of ibuprofen and other non-aspirin NSAIDs such as naproxen and sulindac reflected a similar reduction in risk (RR, 0.56; 95% CI, 0.33β0.95). No association was found for the non-NSAID analgesic acetaminophen. Our findings provide support for an inverse association between current, regular ibuprofen use and breast cancer recurrence.
datePublished:2007-04-03T00:00:00Z
dateModified:2007-04-03T00:00:00Z
pageStart:613
pageEnd:620
sameAs:https://doi.org/10.1007/s10552-007-9003-y
keywords:
Anti-inflammatory agents
Non-steroidal
Breast neoplasms
Recurrence
Chemoprevention
Cancer Research
Biomedicine
general
Oncology
Public Health
Epidemiology
Hematology
image:
isPartOf:
name:Cancer Causes & Control
issn:
1573-7225
0957-5243
volumeNumber:18
type:
Periodical
PublicationVolume
publisher:
name:Kluwer Academic Publishers
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Marilyn L. Kwan
affiliation:
name:Kaiser Permanente
address:
name:Division of Research, Kaiser Permanente, Oakland, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Laurel A. Habel
affiliation:
name:Kaiser Permanente
address:
name:Division of Research, Kaiser Permanente, Oakland, USA
type:PostalAddress
type:Organization
type:Person
name:Martha L. Slattery
affiliation:
name:University of Utah
address:
name:University of Utah, Salt Lake City, USA
type:PostalAddress
type:Organization
type:Person
name:Bette Caan
affiliation:
name:Kaiser Permanente
address:
name:Division of Research, Kaiser Permanente, Oakland, USA
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:NSAIDs and breast cancer recurrence in a prospective cohort study
description:We examined the association between NSAID use and breast cancer recurrence in a prospective cohort of 2,292 early-stage breast cancer survivors diagnosed from 1997 to 2000 participating in the Life After Cancer Epidemiology (LACE) Study. From 2000 to 2002, mailed questionnaires were used to obtain information on aspirin, ibuprofen, and other NSAID use and subsequent breast cancer events. A total of 270 recurrences (local, regional, and distant disease and new primary breast cancers) were reported and verified by medical record review. Cox proportional hazard models were used to estimate rate ratios (RR) and 95% confidence intervals (CI), adjusting for age at diagnosis, race, cancer stage, tamoxifen treatment, chemotherapy use, body mass index, and cyclooxygenase-2 (COX2) inhibitor use. Current, regular use (at least three days per week at time of questionnaire administration) of ibuprofen (RR, 0.56; 95% CI, 0.32β0.98), but not aspirin (RR, 1.09; 95% CI, 0.74β1.61), was associated with a statistically significant decreased risk of breast cancer recurrence. The combination of ibuprofen and other non-aspirin NSAIDs such as naproxen and sulindac reflected a similar reduction in risk (RR, 0.56; 95% CI, 0.33β0.95). No association was found for the non-NSAID analgesic acetaminophen. Our findings provide support for an inverse association between current, regular ibuprofen use and breast cancer recurrence.
datePublished:2007-04-03T00:00:00Z
dateModified:2007-04-03T00:00:00Z
pageStart:613
pageEnd:620
sameAs:https://doi.org/10.1007/s10552-007-9003-y
keywords:
Anti-inflammatory agents
Non-steroidal
Breast neoplasms
Recurrence
Chemoprevention
Cancer Research
Biomedicine
general
Oncology
Public Health
Epidemiology
Hematology
image:
isPartOf:
name:Cancer Causes & Control
issn:
1573-7225
0957-5243
volumeNumber:18
type:
Periodical
PublicationVolume
publisher:
name:Kluwer Academic Publishers
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Marilyn L. Kwan
affiliation:
name:Kaiser Permanente
address:
name:Division of Research, Kaiser Permanente, Oakland, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Laurel A. Habel
affiliation:
name:Kaiser Permanente
address:
name:Division of Research, Kaiser Permanente, Oakland, USA
type:PostalAddress
type:Organization
type:Person
name:Martha L. Slattery
affiliation:
name:University of Utah
address:
name:University of Utah, Salt Lake City, USA
type:PostalAddress
type:Organization
type:Person
name:Bette Caan
affiliation:
name:Kaiser Permanente
address:
name:Division of Research, Kaiser Permanente, Oakland, USA
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Cancer Causes & Control
issn:
1573-7225
0957-5243
volumeNumber:18
Organization:
name:Kluwer Academic Publishers
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Kaiser Permanente
address:
name:Division of Research, Kaiser Permanente, Oakland, USA
type:PostalAddress
name:Kaiser Permanente
address:
name:Division of Research, Kaiser Permanente, Oakland, USA
type:PostalAddress
name:University of Utah
address:
name:University of Utah, Salt Lake City, USA
type:PostalAddress
name:Kaiser Permanente
address:
name:Division of Research, Kaiser Permanente, Oakland, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Marilyn L. Kwan
affiliation:
name:Kaiser Permanente
address:
name:Division of Research, Kaiser Permanente, Oakland, USA
type:PostalAddress
type:Organization
email:[email protected]
name:Laurel A. Habel
affiliation:
name:Kaiser Permanente
address:
name:Division of Research, Kaiser Permanente, Oakland, USA
type:PostalAddress
type:Organization
name:Martha L. Slattery
affiliation:
name:University of Utah
address:
name:University of Utah, Salt Lake City, USA
type:PostalAddress
type:Organization
name:Bette Caan
affiliation:
name:Kaiser Permanente
address:
name:Division of Research, Kaiser Permanente, Oakland, USA
type:PostalAddress
type:Organization
PostalAddress:
name:Division of Research, Kaiser Permanente, Oakland, USA
name:Division of Research, Kaiser Permanente, Oakland, USA
name:University of Utah, Salt Lake City, USA
name:Division of Research, Kaiser Permanente, Oakland, USA
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {π}(86)
- https://www.springernature.com/gp/authors income
- What's the financial gain of https://link.springernature.com/home/?
- What is the monthly revenue of https://order.springer.com/public/cart?
- Find out how much https://submission.nature.com/new-submission/10552/3 earns monthly
- Profit of https://www.springernature.com/gp/librarians/licensing/agc/journals
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14522941?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Breast%20cancer%20and%20nonsteroidal%20anti-inflammatory%20drugs%3A%20prospective%20results%20from%20the%20Women%E2%80%99s%20Health%20Initiative&journal=Cancer%20Res&volume=63&issue=18&pages=6096-6101&publication_year=2003&author=Harris%2CRE&author=Chlebowski%2CRT&author=Jackson%2CRD
- Get to know what's the income of https://doi.org/10.1054%2Fbjoc.2000.1709
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11336469?
- How much does http://scholar.google.com/scholar_lookup?&title=Breast%20cancer%20and%20NSAID%20use%3A%20a%20meta-analysis&journal=Br%20J%20Cancer&doi=10.1054%2Fbjoc.2000.1709&volume=84&issue=9&pages=1188-1192&publication_year=2001&author=Khuder%2CSA&author=Mutgi%2CAB rake in every month?
- What is the monthly revenue of https://doi.org/10.1023%2FB%3ACACO.0000007973.59863.66?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14750530
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Association%20between%20non-steroidal%20anti-inflammatory%20drugs%20%28NSAIDs%29%20and%20invasive%20breast%20cancer%20and%20carcinoma%20in%20situ%20of%20the%20breast&journal=Cancer%20Causes%20Control&doi=10.1023%2FB%3ACACO.0000007973.59863.66&volume=14&issue=10&pages=915-922&publication_year=2003&author=Moorman%2CPG&author=Grubber%2CJM&author=Millikan%2CRC&author=Newman%2CB produce monthly?
- How much income does https://doi.org/10.1159%2F000084818 have?
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15802928 is on a monthly basis
- See how much http://scholar.google.com/scholar_lookup?&title=Association%20of%20regular%20aspirin%20use%20and%20breast%20cancer%20risk&journal=Oncology&doi=10.1159%2F000084818&volume=68&issue=1&pages=40-47&publication_year=2005&author=Swede%2CH&author=Mirand%2CAL&author=Menezes%2CRJ&author=Moysich%2CKB makes per month
- What's the total monthly financial gain of https://doi.org/10.1001%2Fjama.291.20.2433?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15161893
- How much profit does http://scholar.google.com/scholar_lookup?&title=Association%20of%20frequency%20and%20duration%20of%20aspirin%20use%20and%20hormone%20receptor%20status%20with%20breast%20cancer%20risk&journal=Jama&doi=10.1001%2Fjama.291.20.2433&volume=291&issue=20&pages=2433-2440&publication_year=2004&author=Terry%2CMB&author=Gammon%2CMD&author=Zhang%2CFF make?
- Profit of https://doi.org/10.1093%2Faje%2Fkwi182
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15972932
- See how much http://scholar.google.com/scholar_lookup?&title=Use%20of%20nonsteroidal%20antiinflammatory%20drugs%20and%20risk%20of%20breast%20cancer%3A%20the%20Case-Control%20Surveillance%20Study%20revisited&journal=Am%20J%20Epidemiol&doi=10.1093%2Faje%2Fkwi182&volume=162&issue=2&pages=165-170&publication_year=2005&author=Zhang%2CY&author=Coogan%2CPF&author=Palmer%2CJR&author=Strom%2CBL&author=Rosenberg%2CL makes per month
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14588079
- Get to know http://scholar.google.com/scholar_lookup?&title=Effects%20of%20non-steroidal%20anti-inflammatory%20drugs%20on%20cancer%20sites%20other%20than%20the%20colon%20and%20rectum%3A%20a%20meta-analysis&journal=BMC%20Cancer&doi=10.1186%2F1471-2407-3-28&volume=3&publication_year=2003&author=Gonzalez-Perez%2CA&author=Garcia%20Rodriguez%2CLA&author=Lopez-Ridaura%2CR's earnings
- How much profit is https://doi.org/10.1001%2Fjama.294.1.47 making per month?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15998890's revenue stream
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Low-dose%20aspirin%20in%20the%20primary%20prevention%20of%20cancer%3A%20the%20Women%E2%80%99s%20Health%20Study%3A%20a%20randomized%20controlled%20trial&journal=Jama&doi=10.1001%2Fjama.294.1.47&volume=294&issue=1&pages=47-55&publication_year=2005&author=Cook%2CNR&author=Lee%2CIM&author=Gaziano%2CJM
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15668504 earns monthly
- http://scholar.google.com/scholar_lookup?&title=Aspirin%20and%20other%20nonsteroidal%20anti-inflammatory%20drugs%20and%20breast%20cancer%20incidence%20in%20a%20large%20U.S.%20cohort&journal=Cancer%20Epidemiol%20Biomarkers%20Prev&volume=14&issue=1&pages=261-264&publication_year=2005&author=Jacobs%2CEJ&author=Thun%2CMJ&author=Connell%2CCJ income
- What are the earnings of https://doi.org/10.1093%2Fjnci%2Fdji140?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15928301 make?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Nonsteroidal%20anti-inflammatory%20drug%20use%20and%20breast%20cancer%20risk%20by%20stage%20and%20hormone%20receptor%20status&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2Fdji140&volume=97&issue=11&pages=805-812&publication_year=2005&author=Marshall%2CSF&author=Bernstein%2CL&author=Anton-Culver%2CH is on a monthly basis
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15986109?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Life%20After%20Cancer%20Epidemiology%20%28LACE%29%20Study%3A%20a%20cohort%20of%20early%20stage%20breast%20cancer%20survivors%20%28United%20States%29&journal=Cancer%20Causes%20Control&doi=10.1007%2Fs10552-004-8340-3&volume=16&issue=5&pages=545-556&publication_year=2005&author=Caan%2CB&author=Sternfeld%2CB&author=Gunderson%2CE&author=Coates%2CA&author=Quesenberry%2CC&author=Slattery%2CML
- How much profit does https://doi.org/10.1001%2Fjama.293.20.2479 generate?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15914748?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Physical%20activity%20and%20survival%20after%20breast%20cancer%20diagnosis&journal=Jama&doi=10.1001%2Fjama.293.20.2479&volume=293&issue=20&pages=2479-2486&publication_year=2005&author=Holmes%2CMD&author=Chen%2CWY&author=Feskanich%2CD&author=Kroenke%2CCH&author=Colditz%2CGA
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Applied%20survival%20analysis%3A%20regression%20modeling%20of%20time%20to%20event%20data&publication_year=1999&author=Hosmer%2CDW&author=Lemeshow%2CS each month?
- How much does https://doi.org/10.1038%2Fnrc1801 earn?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16491072 earn?
- Profit of http://scholar.google.com/scholar_lookup?&title=Non-steroidal%20anti-inflammatory%20drugs%20for%20cancer%20prevention%3A%20promise%2C%20perils%20and%20pharmacogenetics&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc1801&volume=6&issue=2&pages=130-140&publication_year=2006&author=Ulrich%2CCM&author=Bigler%2CJ&author=Potter%2CJD
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16531064 bring in?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Cyclooxygenase-2%20as%20a%20target%20for%20anticancer%20drug%20development&journal=Crit%20Rev%20Oncol%20Hematol&volume=59&issue=1&pages=51-64&publication_year=2006&author=Meric%2CJB&author=Rottey%2CS&author=Olaussen%2CK each month?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10652588 make?
- How much does http://scholar.google.com/scholar_lookup?&title=Comparative%20chemopreventive%20activity%20of%20ibuprofen%20and%20N-%284-hydroxyphenyl%29%20retinamide%20against%20the%20development%20and%20growth%20of%20rat%20mammary%20adenocarcinomas&journal=Anticancer%20Res&volume=19&issue=4B&pages=3031-3036&publication_year=1999&author=Alshafie%2CGA&author=Harris%2CRE&author=Robertson%2C earn?
- How much does https://doi.org/10.1016%2FS0304-3835%2897%2900387-X rake in every month?
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9464506 have?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Ibuprofen-induced%20inhibition%20of%20cyclooxygenase%20isoform%20gene%20expression%20and%20regression%20of%20rat%20mammary%20carcinomas&journal=Cancer%20Lett&doi=10.1016%2FS0304-3835%2897%2900387-X&volume=122&issue=1%E2%80%932&pages=165-175&publication_year=1998&author=Robertson%2CFM&author=Parrett%2CML&author=Joarder%2CFS?
- How much money does https://doi.org/10.1677%2Ferc.0.0090015 generate?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11914180?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Progress%20in%20breast%20cancer%20chemoprevention&journal=Endocr%20Relat%20Cancer&doi=10.1677%2Ferc.0.0090015&volume=9&issue=1&pages=15-32&publication_year=2002&author=Arun%2CB&author=Hortobagyi%2CGN?
- https://doi.org/10.1093%2Fjnci%2F90.6.455 income
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9521170 bring in?
- How much does http://scholar.google.com/scholar_lookup?&title=Expression%20of%20cyclooxygenase-1%20and%20cyclooxygenase-2%20in%20human%20breast%20cancer&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2F90.6.455&volume=90&issue=6&pages=455-460&publication_year=1998&author=Hwang%2CD&author=Scollard%2CD&author=Byrne%2CJ&author=Levine%2CE gross monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Cyclooxygenase-2%20gene%20expression%20in%20human%20breast%20cancer&journal=Int%20J%20Oncol&volume=10&pages=503-508&publication_year=1997&author=Parrett%2CM&author=Harris%2CR&author=Joarder%2CF&author=Ross%2CM&author=Clausen%2CK&author=Robertson%2CF rake in every month?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12037025
- Find out how much http://scholar.google.com/scholar_lookup?&title=Cyclo-oxygenase%202%20expression%20is%20associated%20with%20angiogenesis%20and%20lymph%20node%20metastasis%20in%20human%20breast%20cancer&journal=J%20Clin%20Pathol&volume=55&issue=6&pages=429-434&publication_year=2002&author=Costa%2CC&author=Soares%2CR&author=Reis-Filho%2CJS&author=Leitao%2CD&author=Amendoeira%2CI&author=Schmitt%2CFC earns monthly
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11830510 pull in?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Prognostic%20significance%20of%20elevated%20cyclooxygenase-2%20expression%20in%20breast%20cancer&journal=Cancer%20Res&volume=62&issue=3&pages=632-635&publication_year=2002&author=Ristimaki%2CA&author=Sivula%2CA&author=Lundin%2CJ bring in?
- How much income is https://citation-needed.springer.com/v2/references/10.1007/s10552-007-9003-y?format=refman&flavour=references earning monthly?
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Marilyn%20L.%20Kwan
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Marilyn%20L.%20Kwan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Laurel%20A.%20Habel bring in?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Laurel%20A.%20Habel%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Martha%20L.%20Slattery?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Martha%20L.%20Slattery%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
- What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Bette%20Caan?
- How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Bette%20Caan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial intake of https://s100.copyright.com/AppDispatchServlet?title=NSAIDs%20and%20breast%20cancer%20recurrence%20in%20a%20prospective%20cohort%20study&author=Marilyn%20L.%20Kwan%20et%20al&contentID=10.1007%2Fs10552-007-9003-y©right=Springer%20Science%20%2B%20Business%20Media%20B.V.&publication=0957-5243&publicationDate=2007-04-03&publisherName=SpringerNature&orderBeanReset=true?
- What is the monthly revenue of https://citation-needed.springer.com/v2/references/10.1007/s10552-007-9003-y?format=refman&flavour=citation?
- How much does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral bring in each month?
- See how much https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research makes per month
- Learn about the earnings of https://www.springernature.com/gp/products
- What's https://www.springernature.com/gp/librarians's gross income?
- How much revenue does https://www.springernature.com/gp/societies generate?
- How much does https://www.springernature.com/gp/partners bring in each month?
- How much does https://www.springer.com/ make?
- How much does https://www.nature.com/ make?
- How much profit does https://www.biomedcentral.com/ generate?
- How much does https://www.palgrave.com/ pull in?
- How much income does https://www.apress.com/ have?
- https://www.springernature.com/gp/legal/ccpa's financial summary
- Get to know what's the income of https://www.springernature.com/gp/info/accessibility
- What's the profit of https://support.springernature.com/en/support/home?
- How much revenue does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations produce monthly?
- How much cash flow does https://www.springernature.com/ have monthly?
Analytics and Tracking {π}
- Google Tag Manager
Libraries {π}
- Clipboard.js
- Prism.js
CDN Services {π¦}
- Crossref